Patient Research In Self-Management of Asthma (PRISMA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00411346|
Recruitment Status : Completed
First Posted : December 14, 2006
Last Update Posted : December 14, 2006
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Procedure: Nurse-led telemonitoring||Phase 4|
At the present day asthma is one of the most common chronic illnesses worldwide and the prevalence is still increasing. Asthma can be treated and controlled with guidance of health care professionals, and self-monitoring is an important aspect in this control.
Respiratory nurses have become common caregivers in the treatment and control of asthma. Advances in information and communication technology have created the potential to monitor the asthma status of patients at a distance, named telemonitoring. These two developments come together in nurse-led telemonitoring programmes. Lung function tests, from which the peak expiratory flow (PEF) is the most commonly used, are recorded into an electronic monitor. By transferring monitor data to a central database a nurse can continuously supervise the disease status of individual patients. The use of stepwise protocols can enable nurses to independently adjust the medication by one step.
Design: Randomized controlled trial comparing a nurse-led telemonitoring programme versus regular care in asthmatic outpatients aged 7 years and older.
Primary outcome parameter: asthma-specific quality of life. Secondary outcome parameters: symptoms, generic quality of life, direct and indirect costs, satisfaction.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||112 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Nurse-Led Telemonitoring Programme in Asthmatic Outpatients: a Randomized Controlled Trial|
|Study Start Date :||January 2003|
|Study Completion Date :||November 2004|
- Asthma-specific quality of life at one year.
- Asthma symptoms at one year
- generic quality of life at one year
- direct and indirect costs during one year
- satisfaction with and feasibility of the intervention at one year.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00411346
|University Hospital Maastricht|
|Maastricht, Limburg, Netherlands, 6202 AZ|
|Study Chair:||Emiel FM Wouters, MD PhD||Department of Respiratory Medicine|